West Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . West Pharmaceutical Services
WST Stock  USD 276.40  1.26  0.46%   
Analyzing historical trends in various income statement and balance sheet accounts from West Pharmaceutical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting West Pharmaceutical's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.1629
Market Capitalization
19.9 B
Enterprise Value Revenue
6.4794
Revenue
3 B
There are currently one hundred twenty fundamental gauges for West Pharmaceutical that can be evaluated and compared over time across peers. All traders should confirm West Pharmaceutical's prevalent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 236.5 M in 2026. Enterprise Value is likely to drop to about 252.4 M in 2026

West Pharmaceutical Total Revenue

3.49 Billion

Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 187.6 M, Total Revenue of 3.5 B or Gross Profit of 1.2 B, as well as many indicators such as Price To Sales Ratio of 7.81, Dividend Yield of 0.0027 or PTB Ratio of 8.42. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
  
Build AI portfolio with West Stock
Check out the analysis of West Pharmaceutical Correlation against competitors.

West Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.4 B4.2 B2.4 B
Slightly volatile
Short and Long Term Debt Total233.1 M351.1 M295.3 M
Pretty Stable
Other Current Liabilities232.3 M221.3 M135.5 M
Slightly volatile
Total Current Liabilities664.6 M633 M388.7 M
Slightly volatile
Total Stockholder Equity3.2 B3.1 B1.7 B
Slightly volatile
Property Plant And Equipment Net2 B1.9 B1 B
Slightly volatile
Retained Earnings4.8 B4.6 B2 B
Slightly volatile
Cash585.2 M557.3 M411.2 M
Slightly volatile
Non Current Assets Total2.5 B2.4 B1.4 B
Slightly volatile
Non Currrent Assets Other70.2 M66.9 M36.2 M
Slightly volatile
Cash And Short Term Investments585.2 M557.3 M412.4 M
Slightly volatile
Net Receivables667.1 M635.4 M335.4 M
Slightly volatile
Common Stock Shares Outstanding74.8 M84.8 M74.4 M
Slightly volatile
Liabilities And Stockholders Equity4.4 B4.2 B2.4 B
Slightly volatile
Non Current Liabilities Total311.4 M472.3 M385.6 M
Very volatile
Inventory455.2 M433.6 M268 M
Slightly volatile
Other Current Assets149.7 M142.6 M75 M
Slightly volatile
Total Liabilities1.2 B1.1 B762.4 M
Slightly volatile
Total Current Assets1.9 B1.8 B1.1 B
Slightly volatile
Short Term Debt21.7 M21.6 M35.3 M
Pretty Stable
Intangible Assets11.8 M12.4 M26.9 M
Slightly volatile
Accounts Payable289 M275.2 M164.3 M
Slightly volatile
Property Plant And Equipment Gross3.7 B3.6 B1.5 B
Slightly volatile
Common Stock Total Equity13 M21.6 M16.4 M
Slightly volatile
Common Stock13.6 M21.6 M16.4 M
Slightly volatile
Other Liabilities107.9 M130.2 M119.8 M
Pretty Stable
Long Term Debt201.4 M182.3 M234.4 M
Slightly volatile
Good Will103.7 M122 M105.7 M
Slightly volatile
Property Plant Equipment2.1 B2 B1 B
Slightly volatile
Current Deferred Revenue35.5 M44.6 M36.7 M
Pretty Stable
Net Tangible Assets3.1 B2.9 B1.6 B
Slightly volatile
Long Term Debt Total194.3 M184.2 M243.7 M
Slightly volatile
Capital Surpluse24.1 M25.4 M166.7 M
Pretty Stable
Long Term Investments140.1 M232.4 M130.3 M
Slightly volatile
Non Current Liabilities Other98.3 M56 M120.1 M
Slightly volatile
Deferred Long Term Asset Charges12 M12.6 M39.6 M
Slightly volatile
Short and Long Term Debt161.8 M154.1 M49.9 M
Slightly volatile
Cash And Equivalents589.9 M557.3 M423 M
Slightly volatile
Net Invested Capital2.5 B3.3 B2 B
Slightly volatile
Net Working Capital1 B1.1 B757.2 M
Slightly volatile
Capital Stock15 M16.9 M18.5 M
Slightly volatile
Capital Lease Obligations96.4 M114.7 M81.5 M
Slightly volatile

West Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization187.6 M178.7 M108 M
Slightly volatile
Total Revenue3.5 B3.3 B2 B
Slightly volatile
Gross Profit1.2 B1.2 B698.5 M
Slightly volatile
Other Operating Expenses2.8 B2.6 B1.6 B
Slightly volatile
Operating Income718 M683.8 M375 M
Slightly volatile
EBIT710.5 M676.7 M367 M
Slightly volatile
EBITDA898.1 M855.4 M475 M
Slightly volatile
Cost Of Revenue2.3 B2.2 B1.3 B
Slightly volatile
Total Operating Expenses492.2 M468.7 M318.2 M
Slightly volatile
Income Before Tax724.7 M690.2 M367.7 M
Slightly volatile
Net Income594.9 M566.6 M299.4 M
Slightly volatile
Income Tax Expense129.8 M123.6 M70.2 M
Slightly volatile
Selling General Administrative200.4 M389.3 M263.7 M
Slightly volatile
Research Development83.4 M79.5 M47.3 M
Slightly volatile
Net Income Applicable To Common Shares594.9 M566.6 M295.7 M
Slightly volatile
Net Income From Continuing Ops283.5 M566.6 M277.4 M
Slightly volatile
Tax Provision86.5 M123.6 M66.3 M
Slightly volatile
Interest Income23.7 M22.5 M11.4 M
Slightly volatile
Reconciled Depreciation130.5 M178.7 M113.8 M
Slightly volatile

West Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.5 M21.5 M20 M
Slightly volatile
Free Cash Flow333.8 M317.9 M196 M
Slightly volatile
Begin Period Cash Flow1 B982 M440.2 M
Slightly volatile
Depreciation187.6 M178.7 M108.5 M
Slightly volatile
Dividends Paid71.4 M68 M41.9 M
Slightly volatile
Capital Expenditures455.2 M433.6 M207.9 M
Slightly volatile
Total Cash From Operating Activities789 M751.4 M403.9 M
Slightly volatile
Net Income594.9 M566.6 M299.8 M
Slightly volatile
End Period Cash Flow585.2 M557.3 M410.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.817.445.3721
Slightly volatile
Dividend Yield0.00270.00280.0064
Slightly volatile
PTB Ratio8.428.026.4042
Slightly volatile
Days Sales Outstanding43.0962.7455.6115
Slightly volatile
Book Value Per Share34.7233.0721.5562
Slightly volatile
Free Cash Flow Yield0.02460.01330.0193
Slightly volatile
Operating Cash Flow Per Share8.468.065.2574
Slightly volatile
Stock Based Compensation To Revenue0.00870.00580.011
Slightly volatile
Capex To Depreciation1.262.181.7183
Slightly volatile
PB Ratio8.428.026.4042
Slightly volatile
EV To Sales7.757.385.3546
Slightly volatile
Free Cash Flow Per Share3.583.412.5557
Slightly volatile
ROIC0.07380.140.1208
Slightly volatile
Inventory Turnover6.375.775.1408
Pretty Stable
Net Income Per Share6.386.073.8814
Slightly volatile
Days Of Inventory On Hand52.0765.5171.757
Pretty Stable
Payables Turnover11.799.098.6895
Pretty Stable
Research And Ddevelopement To Revenue0.01670.02150.0224
Pretty Stable
Capex To Revenue0.110.150.0994
Slightly volatile
Cash Per Share6.275.975.4305
Slightly volatile
POCF Ratio34.5832.9427.1123
Slightly volatile
Interest Coverage19418564.1387
Slightly volatile
Payout Ratio0.130.140.202
Slightly volatile
Capex To Operating Cash Flow0.770.660.5784
Slightly volatile
PFCF Ratio81.7577.8662.2766
Slightly volatile
Days Payables Outstanding28.7741.5843.0736
Pretty Stable
Income Quality1.451.531.5904
Slightly volatile
ROE0.0960.170.1526
Slightly volatile
EV To Operating Cash Flow34.3232.6927.1921
Slightly volatile
PE Ratio23.5743.6837.3388
Slightly volatile
Return On Tangible Assets0.130.13970.1127
Slightly volatile
EV To Free Cash Flow81.1477.2863.133
Slightly volatile
Earnings Yield0.04570.02370.0318
Slightly volatile
Intangibles To Total Assets0.02740.02890.0622
Slightly volatile
Current Ratio1.842.522.7064
Very volatile
Tangible Book Value Per Share33.2131.6319.797
Slightly volatile
Receivables Turnover7.626.026.6931
Slightly volatile
Graham Number70.5967.2343.3072
Slightly volatile
Shareholders Equity Per Share34.7233.0721.8628
Slightly volatile
Debt To Equity0.120.130.2364
Slightly volatile
Capex Per Share4.884.652.7017
Slightly volatile
Revenue Per Share37.4535.6626.3054
Slightly volatile
Interest Debt Per Share2.563.84.0381
Pretty Stable
Debt To Assets0.09150.09640.1436
Slightly volatile
Enterprise Value Over EBITDA30.1528.7222.6906
Slightly volatile
Short Term Coverage Ratios55.7231.2880.6569
Pretty Stable
Price Earnings Ratio23.5743.6837.3388
Slightly volatile
Operating Cycle95.16128127
Slightly volatile
Price Book Value Ratio8.428.026.4042
Slightly volatile
Days Of Payables Outstanding28.7741.5843.0736
Pretty Stable
Dividend Payout Ratio0.130.140.202
Slightly volatile
Price To Operating Cash Flows Ratio34.5832.9427.1123
Slightly volatile
Price To Free Cash Flows Ratio81.7577.8662.2766
Slightly volatile
Pretax Profit Margin0.20.190.1624
Slightly volatile
Ebt Per Ebit0.981.160.9804
Slightly volatile
Operating Profit Margin0.10.180.1595
Slightly volatile
Effective Tax Rate0.290.210.2352
Slightly volatile
Company Equity Multiplier2.11.561.6039
Slightly volatile
Long Term Debt To Capitalization0.07670.08080.1554
Slightly volatile
Total Debt To Capitalization0.110.120.182
Slightly volatile
Return On Capital Employed0.10.170.1593
Slightly volatile
Debt Equity Ratio0.120.130.2364
Slightly volatile
Ebit Per Revenue0.10.180.1595
Slightly volatile
Quick Ratio1.291.91.9738
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.031.351.518
Slightly volatile
Net Income Per E B T0.580.740.7542
Slightly volatile
Cash Ratio0.470.790.9515
Slightly volatile
Cash Conversion Cycle95.2511189.1022
Slightly volatile
Operating Cash Flow Sales Ratio0.120.20.1766
Slightly volatile
Days Of Inventory Outstanding52.0765.5171.757
Pretty Stable
Days Of Sales Outstanding43.0962.7455.6115
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.240.380.4246
Slightly volatile
Cash Flow Coverage Ratios2.021.931.3191
Slightly volatile
Price To Book Ratio8.428.026.4042
Slightly volatile
Fixed Asset Turnover1.581.541.9625
Pretty Stable
Capital Expenditure Coverage Ratio1.271.561.8771
Slightly volatile
Price Cash Flow Ratio34.5832.9427.1123
Slightly volatile
Enterprise Value Multiple30.1528.7222.6906
Slightly volatile
Debt Ratio0.09150.09640.1436
Slightly volatile
Cash Flow To Debt Ratio2.021.931.3191
Slightly volatile
Price Sales Ratio7.817.445.3721
Slightly volatile
Return On Assets0.130.120.1066
Slightly volatile
Asset Turnover0.980.910.8646
Pretty Stable
Net Profit Margin0.160.150.1274
Slightly volatile
Gross Profit Margin0.260.310.3318
Slightly volatile
Price Fair Value8.428.026.4042
Slightly volatile
Return On Equity0.0960.170.1526
Slightly volatile

West Pharmaceutical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.5 M442.1 M456.5 M
Very volatile
Enterprise Value252.4 M374.8 M393.1 M
Very volatile

West Fundamental Market Drivers

Forward Price Earnings36.9004
Cash And Short Term Investments484.6 M

West Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About West Pharmaceutical Financial Statements

West Pharmaceutical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on West Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue44.6 M35.5 M
Total Revenue3.3 B3.5 B
Cost Of Revenue2.2 B2.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.15  0.11 
Revenue Per Share 35.66  37.45 
Ebit Per Revenue 0.18  0.10 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY